靶向细胞焦亡在口腔颌面部疾病中的研究解读
口腔颌面部持续暴露于微生物、机械应力与致癌刺激,人临床标本中检出GSDMD/GSDME剪切体,涉及牙周炎、种植体周炎、根尖周炎、口腔扁平苔藓和口腔黏膜下纤维化。机制涉及炎症小体组装、caspase活化与gasdermin剪切导致细胞焦亡性裂解,动物模型显示遗传或药理干预可减轻骨丧失、纤维化与炎症,而口腔鳞癌中诱导焦亡可增强抗肿瘤免疫。
要点
- 临床标本中检出GSDMD/GSDME剪切体,支持焦亡参与多种口腔疾病。
- 动物模型显示抑制caspase-1或NLRP3可减轻牙周骨丧失与纤维化。
- 口腔鳞癌中诱导焦亡可增强抗肿瘤免疫,体现疾病背景依赖性。
核心结论
- 精准调控细胞焦亡被视为口腔颌面部疾病管理的新前沿。
研究设计与样本
- 综述汇总人临床标本、小鼠与大鼠模型及猴和兔模型的功能研究证据。
主要发现
- 牙周炎、种植体周炎、根尖周炎、口腔扁平苔藓和口腔黏膜下纤维化临床标本中检出cleaved GSDMD/GSDME。
- 小鼠牙周炎模型中遗传敲除caspase-1减轻牙槽骨丧失。
- 大鼠口腔黏膜下纤维化模型中药物抑制NLRP3通过抑制焦亡减轻纤维化并减缓疾病进展。
- 种植体周炎中抑制NLRP3抑制巨噬细胞焦亡并促进成骨。
- 根尖周炎模型中GSDMD和GSDME激活触发焦亡并加重牙髓与根尖周炎症。
关键数值与推荐
- 人临床标本中检出cleaved GSDMD/GSDME,涉及牙周炎、种植体周炎、根尖周炎、口腔扁平苔藓和口腔黏膜下纤维化。
- 机制核心为炎症小体(如NLRP3)组装导致caspase激活与gasdermin(如GSDMD、GSDME)剪切,引起焦亡性细胞裂解。
- 口腔鳞癌中诱导焦亡可强效刺激抗肿瘤免疫。
- 新兴策略包括牙髓干细胞细胞治疗在猴模型中减轻焦亡并促进神经再生。
- 纳米材料如血管生成素偶联碳纳米管在兔模型中调节焦亡相关通路以增强骨再生。
临床怎么用
- 对牙周炎、种植体周炎和根尖周炎可探索抑制NLRP3/caspase-1轴以减轻焦亡相关炎症与骨丧失。
- 对口腔黏膜下纤维化可考虑靶向NLRP3抑制焦亡以减缓纤维化进展。
- 对口腔鳞癌则需评估诱导焦亡以增强抗肿瘤免疫的策略,注意疾病背景差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The oral and maxillofacial region is a complex microenvironment continuously exposed to microbial challenge, mechanical stress, and oncogenic stimuli. Accumulating human evidence firmly implicates pyroptosis in the pathogenesis of major oral and maxillofacial diseases, with cleaved gasdermin D (GSDMD)/gasdermin E (GSDME) detected in clinical specimens of periodontitis, peri-implantitis, apical periodontitis, oral lichen planus, and oral submucous fibrosis. The central mechanism involves inflammasome assembly (eg, NLRP3), leading to caspase activation, gasdermin cleavage (eg, GSDMD, GSDME), and consequent pyroptotic cell lysis. Functional in vivo studies establish a direct causal link: genetic ablation of caspase-1 attenuates alveolar bone loss in murine periodontitis models, while pharmacologic inhibition of NLRP3 mitigates fibrosis and slows disease progression in rat models of oral submucous fibrosis by suppressing pyroptosis. In peri-implantitis, NLRP3 suppression inhibits macrophage pyroptosis and promotes osteogenesis. Similarly, the activation of GSDMD and GSDME is shown to trigger pyroptosis and exacerbate pulpal and periapical inflammation in apical periodontitis models. Conversely, in oral squamous cell carcinoma, pyroptosis induction potently stimulates anti-tumor immunity. This context-dependent duality of pyroptosis provides the rationale for precision medicine. Emerging strategies reflecting this approach include cell-based therapies using dental pulp stem cells to alleviate pyroptosis and promote nerve regeneration in macaque models as well as advanced nanomaterials such as angiopoietin-coupled carbon nanotubes that modulate pyroptosis-related pathways to enhance bone regeneration in rabbits. Collectively, these insights position the precise modulation of pyroptosis as a new frontier in the management of oral and maxillofacial diseases.
引用
- Tang L, Wang Y, Yu Z, et al. Targeting Pyroptosis in Oral and Maxillofacial Diseases. J Dent Res. 2026. PMID: 42198993. doi:10.1177/00220345261443990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。